FIELD: medicine, ophthalmology. SUBSTANCE: it is suggested to introduce prospidine into subconjunctival space of an eyeball at the dosage of 0.3 ml, then introduction should be repeated in 10- 14 d. EFFECT: higher efficiency in treating neovasculogenesis and excluding "an abolition phenomenon", decreased number of complications due to the usage of cytostatics. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF RECURRENT PTERYGIUM MEDICAL TREATMENT | 2004 |
|
RU2326668C2 |
| METHOD FOR TREATING SENILE MACULAR DEGENERATION AT NEOVASCULAR SYNDROME | 2003 |
|
RU2271208C2 |
| METHOD FOR TREATING ENDOGENOUS AND POSTOPERATIVE UVEITIS | 1996 |
|
RU2107480C1 |
| CORNEA NEOVASCULARISATION AGGRESSIVE APPROACH | 2008 |
|
RU2369364C1 |
| METHOD OF PREVENTION OF SUBEPITHELIAL FIBROSIS AFTER PRK | 2004 |
|
RU2351336C2 |
| METHOD OF SELECTING THERAPY OF CHRONIC INFLAMMATORY DISEASES OF EYE SURFACE BASED ON CONTROLLED POTENTIATION OF EXUDATIVE REACTION BY MEANS OF MECHANICAL OR IMMUNE IMPACT | 2009 |
|
RU2421193C2 |
| METHOD FOR DETERMINING DIFFERENTIATED TREATMENT INDICATIONS FOR EARLY HYPERTENSION PATIENTS AFTER HAVING ANTIGLAUCOMA OPERATIONS OF FILTERING TYPE | 2006 |
|
RU2308254C1 |
| ANTIBACTERIAL DRUG IN FORM OF OINTMENT FOR TREATING EYE DISEASES IN ANIMALS | 2015 |
|
RU2580631C1 |
| METHOD FOR TREATING RHEUMATOID ARTHRITIS | 2001 |
|
RU2199320C1 |
| AGENT FOR COPING WITH STEROID RESISTANCE | 2009 |
|
RU2404792C1 |
